These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 38041911)

  • 1. A comprehensive review on 3D tissue models: Biofabrication technologies and preclinical applications.
    Xie R; Pal V; Yu Y; Lu X; Gao M; Liang S; Huang M; Peng W; Ozbolat IT
    Biomaterials; 2024 Jan; 304():122408. PubMed ID: 38041911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D bioprinting for drug discovery and development in pharmaceutics.
    Peng W; Datta P; Ayan B; Ozbolat V; Sosnoski D; Ozbolat IT
    Acta Biomater; 2017 Jul; 57():26-46. PubMed ID: 28501712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Strategies to Vascularize 3D Physiologically Relevant Models.
    Dellaquila A; Le Bao C; Letourneur D; Simon-Yarza T
    Adv Sci (Weinh); 2021 Oct; 8(19):e2100798. PubMed ID: 34351702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D bioprinting of functional tissue models for personalized drug screening and in vitro disease modeling.
    Ma X; Liu J; Zhu W; Tang M; Lawrence N; Yu C; Gou M; Chen S
    Adv Drug Deliv Rev; 2018 Jul; 132():235-251. PubMed ID: 29935988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomaterial-based 3D bioprinting strategy for orthopedic tissue engineering.
    Chae S; Cho DW
    Acta Biomater; 2023 Jan; 156():4-20. PubMed ID: 35963520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traction of 3D and 4D Printing in the Healthcare Industry: From Drug Delivery and Analysis to Regenerative Medicine.
    Osouli-Bostanabad K; Masalehdan T; Kapsa RMI; Quigley A; Lalatsa A; Bruggeman KF; Franks SJ; Williams RJ; Nisbet DR
    ACS Biomater Sci Eng; 2022 Jul; 8(7):2764-2797. PubMed ID: 35696306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developments with 3D bioprinting for novel drug discovery.
    Satpathy A; Datta P; Wu Y; Ayan B; Bayram E; Ozbolat IT
    Expert Opin Drug Discov; 2018 Dec; 13(12):1115-1129. PubMed ID: 30384781
    [No Abstract]   [Full Text] [Related]  

  • 8. Strategies for 3D bioprinting of spheroids: A comprehensive review.
    Banerjee D; Singh YP; Datta P; Ozbolat V; O'Donnell A; Yeo M; Ozbolat IT
    Biomaterials; 2022 Dec; 291():121881. PubMed ID: 36335718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioprinting for vascular and vascularized tissue biofabrication.
    Datta P; Ayan B; Ozbolat IT
    Acta Biomater; 2017 Mar; 51():1-20. PubMed ID: 28087487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue and Organ 3D Bioprinting.
    Xia Z; Jin S; Ye K
    SLAS Technol; 2018 Aug; 23(4):301-314. PubMed ID: 29474789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioprinting for Human Respiratory and Gastrointestinal In Vitro Models.
    Estermann M; Bisig C; Septiadi D; Petri-Fink A; Rothen-Rutishauser B
    Methods Mol Biol; 2020; 2140():199-215. PubMed ID: 32207114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in tissue engineering of vasculature through three-dimensional bioprinting.
    Zhu J; Wang Y; Zhong L; Pan F; Wang J
    Dev Dyn; 2021 Dec; 250(12):1717-1738. PubMed ID: 34115420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D-bioprinted all-inclusive bioanalytical platforms for cell studies.
    Mazrouei R; Velasco V; Esfandyarpour R
    Sci Rep; 2020 Sep; 10(1):14669. PubMed ID: 32887912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Progress in 3D Bioprinting of Tissue Analogs.
    Zhang S; Wang H
    SLAS Technol; 2019 Feb; 24(1):70-78. PubMed ID: 30257593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Converging functionality: Strategies for 3D hybrid-construct biofabrication and the role of composite biomaterials for skeletal regeneration.
    Alcala-Orozco CR; Cui X; Hooper GJ; Lim KS; Woodfield TBF
    Acta Biomater; 2021 Sep; 132():188-216. PubMed ID: 33713862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-dimensional nanomaterials-added dynamism in 3D printing and bioprinting of biomedical platforms: Unique opportunities and challenges.
    Gaihre B; Potes MA; Serdiuk V; Tilton M; Liu X; Lu L
    Biomaterials; 2022 May; 284():121507. PubMed ID: 35421800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascularization Strategies in 3D Cell Culture Models: From Scaffold-Free Models to 3D Bioprinting.
    Anthon SG; Valente KP
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing.
    Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ
    Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D bioprinted liver tissue and disease models: Current advances and future perspectives.
    Sun L; Wang Y; Zhang S; Yang H; Mao Y
    Biomater Adv; 2023 Sep; 152():213499. PubMed ID: 37295133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancements in Research on Constructing Physiological and Pathological Liver Models and Their Applications Utilizing Bioprinting Technology.
    Ming Z; Tang X; Liu J; Ruan B
    Molecules; 2023 Apr; 28(9):. PubMed ID: 37175094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.